TGFB1 and pulmonary fibrosis: This study underpins the anti-fibrotic property of TXNIP in pulmonary fibrosis through attenuation of TGF-β1 signaling and emphasizes that TXNIP is unstable under TGF-β1 treatment, but can be stabilized by USP13.